Senegal will continue treating COVID-19 patients with hydroxychloroquine, a senior health official said on Wednesday, despite a recent study indicating that the anti-malarial drug is ineffective and potentially harmful.
Authorities in the West African state opted to provide consenting patients with the drug early on during its coronavirus outbreak, citing promising clinical results.
Chloroquine and its derivative hydroxychloroquine have been used for decades against malaria and are considered cheap and safe when used correctly.
US President Donald Trump promoted its use and stunned his own administration earlier this month by revealing he was taking it as a preventive measure against the virus.
But even as countries around the world rushed to use the anti-malarials to fight COVID-19, experts urged caution and warned that the drugs can have potentially serious side effects.
A study of nearly 100,000 COVID-19 patients, released on Friday, appeared to confirm some of those concerns.
Published in the medical journal The Lancet, the study found that chloroquine and hydroxychloroquine do not benefit hospitalised patients — and even increase the risk of death and heart arrhythmia.
It recommended against using either drug outside of clinical trials.
Abdoulaye Bousso, who heads Senegal’s Centre for Health Emergency Operations, told AFP on Wednesday that the country’s hydroxychloroquine treatment programme would nonetheless continue, without offering further details.
The infectious-diseases doctor who is spearheading Senegal’s treatment of COVID-19 patients, Moussa Seydi, did not respond to requests for comment. Nor did the health ministry.
The World Health Organization said on Monday it had temporarily suspended clinical trials of hydroxychloroquine as a potential treatment for coronavirus following the Lancet study.
Scientific community divided
But medical authorities worldwide still appear divided on the use and potential harmfulness of the drugs.
France decided to ban it as a COVID-19 treatment on Wednesday, for example, while Brazilian authorities indicated that they would continue using the drug.
Seydi, the Senegalese infectious-diseases doctor, had previously said that hydroxychloroquine is offered only to consenting patients, and after medical staff perform a cardiogram.
Senegal has so far been spared a coronavirus outbreak on a par with Europe and the United States.
Authorities have recorded 3,235 cases to date, with 38 fatalities.
Latest Stories
-
Fitch affirms ETI at B-; Outlook stable
38 mins -
Bawumia meets Pope Francis
46 mins -
Former Bibiani GoldStars midfielder Frank Adjei Jr continues fine form in Swedish League
50 mins -
J.B. Dankwah Adu’s Murder: Court orders Sexy Dondon to open his defence
53 mins -
Marrakech 2024: Five para-athletes to represent Ghana in WPA Grand Prix in Morocco
1 hour -
U.S Senate approves bill to ban TikTok
1 hour -
T-Pain involved in hit-and-run, warns culprit he’ll find them
1 hour -
Cedi hits GH¢14.00 to a dollar; depreciates 12.08%
1 hour -
Major portions of Kasoa-Winneba road to open to traffic in 8 months
1 hour -
Kwadaso onion traders reject new location, express fear over future eviction
2 hours -
Pensions: 81% of pensioners had benefit shortfalls in 2020 – Abdallah Mashud
2 hours -
All Regional Games: Torch relay ceremony hits Oti Region
2 hours -
CSO calls for immediate removal of COCOBOD CEO from office
2 hours -
How a young female geologist’s thesis is paving the way for Ghana’s Green Mineral Future 5 decades later
2 hours -
Pensions: The last time government paid Tier-2 funds was in June 2023 – Angel Carbonu
2 hours